vs
Side-by-side financial comparison of Canaan Inc. (CAN) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $18.9M, roughly 1.1× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -18.4%, a 33.0% gap on every dollar of revenue.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
CAN vs ELMD — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $20.8M | $18.9M |
| Net Profit | $-3.8M | $2.8M |
| Gross Margin | 99.9% | 78.4% |
| Operating Margin | -15.9% | 19.2% |
| Net Margin | -18.4% | 14.6% |
| Revenue YoY | — | 16.3% |
| Net Profit YoY | — | 40.3% |
| EPS (diluted) | $-0.05 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | $18.9M | ||
| Q3 25 | $13.8M | $16.9M | ||
| Q2 25 | $11.4M | $17.4M | ||
| Q1 25 | — | $15.7M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | $10.2M | $14.7M | ||
| Q2 24 | $4.8M | $14.8M | ||
| Q1 24 | — | $13.9M |
| Q4 25 | $-3.8M | $2.8M | ||
| Q3 25 | $-1.5M | $2.1M | ||
| Q2 25 | $-11.9M | $2.2M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | $-10.4M | $1.5M | ||
| Q2 24 | $-5.4M | $1.8M | ||
| Q1 24 | — | $1.5M |
| Q4 25 | 99.9% | 78.4% | ||
| Q3 25 | 99.9% | 78.1% | ||
| Q2 25 | 99.9% | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | 99.9% | 78.3% | ||
| Q2 24 | 99.8% | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | -15.9% | 19.2% | ||
| Q3 25 | -27.0% | 15.8% | ||
| Q2 25 | -45.5% | 17.5% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | -77.2% | 13.2% | ||
| Q2 24 | -193.9% | 15.7% | ||
| Q1 24 | — | 13.3% |
| Q4 25 | -18.4% | 14.6% | ||
| Q3 25 | -11.0% | 12.6% | ||
| Q2 25 | -104.4% | 12.7% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | -102.7% | 10.0% | ||
| Q2 24 | -112.3% | 12.3% | ||
| Q1 24 | — | 10.8% |
| Q4 25 | $-0.05 | $0.32 | ||
| Q3 25 | $-0.02 | $0.25 | ||
| Q2 25 | $-0.25 | $0.26 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.8M |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | $45.4M |
| Total Assets | $92.5M | $54.9M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $15.3M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $52.4M | $45.4M | ||
| Q3 25 | $44.7M | $44.7M | ||
| Q2 25 | $33.8M | $43.2M | ||
| Q1 25 | — | $43.9M | ||
| Q4 24 | — | $43.6M | ||
| Q3 24 | $43.6M | $41.5M | ||
| Q2 24 | $56.8M | $44.5M | ||
| Q1 24 | — | $42.5M |
| Q4 25 | $92.5M | $54.9M | ||
| Q3 25 | $81.7M | $53.6M | ||
| Q2 25 | $78.0M | $53.8M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $52.3M | ||
| Q3 24 | $69.3M | $48.9M | ||
| Q2 24 | $73.7M | $52.2M | ||
| Q1 24 | — | $48.9M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.0M |
| Free Cash FlowOCF − Capex | — | $2.4M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | — | $169.0K | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-83.0K | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 21.4% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 30.1% | ||
| Q1 24 | — | 9.1% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAN
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |